1. Volume 68, Issue 4, Pages 1840-1848 (October 2005)
25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy 
Giorgio Coen, Daniela Mantella, Micaela Manni, Alessandro Balducci, Italo Nofroni, Daniela Sardella, Paola Ballanti, Ermanno Bonucci 
Kidney International 
Volume 68, Issue 4, Pages (October 2005)
DOI: /j x
Copyright © 2005 International Society of Nephrology Terms and Conditions

2. Figure 1
Monthly distribution of blood sampling for 25-hydroxyvitamin D (25-OHD) assay. The lines set the limits of 25-OHD groups.
Kidney International  , DOI: ( /j x)
Copyright © 2005 International Society of Nephrology Terms and Conditions

3. Figure 2
Serum calcitriol versus 25-hydroxyvitamin D (25-OHD) in 53 patients.
Kidney International  , DOI: ( /j x)
Copyright © 2005 International Society of Nephrology Terms and Conditions

4. Figure 3
Bone formation rate/bone surface (BFR/BS) versus 25-hydroxyvitamin D (25-OHD) serum levels in groups and group 3. Regression lines are also reported.
Kidney International  , DOI: ( /j x)
Copyright © 2005 International Society of Nephrology Terms and Conditions

5. Figure 4
Bone formation rate/bone surface (BFR/BS) in the patients with increasing 25-hydroxyvitamin D (25-OHD) levels. Number of patients in each group are recorded.
Kidney International  , DOI: ( /j x)
Copyright © 2005 International Society of Nephrology Terms and Conditions

6. Figure 5
Osteoid thickness versus intact parathyroid hormone (iPTH) serum levels in the patients with serum 25-OHD values 0-20 (A) and >30 ng/mL (B).
Kidney International  , DOI: ( /j x)
Copyright © 2005 International Society of Nephrology Terms and Conditions